| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute stress cardiomyopathy
|
Wittstein, Ilan S.
|
|
2008
|
|
2 |
p. 61-68
|
artikel
|
| 2 |
Adenosine A1 antagonists and the cardiorenal syndrome
|
Gottlieb, Stephen S.
|
|
2008
|
|
2 |
p. 105-109
|
artikel
|
| 3 |
Altered Breathing Syndrome in Heart Failure: Newer Insights and Treatment Options
|
Tomita, Yasuhiro
|
|
2015
|
|
2 |
p. 158-165
|
artikel
|
| 4 |
Androgen Deficiency in Heart Failure
|
Güder, Gülmisal
|
|
2011
|
|
2 |
p. 131-139
|
artikel
|
| 5 |
Anemia and the potential role of erythropoiesis-stimulating agents in heart failure
|
Faraz, Haroon A.
|
|
2008
|
|
2 |
p. 83-90
|
artikel
|
| 6 |
A Rational Approach to Assess Volume Status in Patients with Decompensated Heart Failure
|
Ahmed, Mustafa
|
|
2012
|
|
2 |
p. 139-147
|
artikel
|
| 7 |
Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective
|
Halbach, Marcel
|
|
2016
|
|
2 |
p. 71-76
|
artikel
|
| 8 |
Beta-blockers in heart failure: Is more better?
|
Baruch, Lawrence
|
|
|
|
2 |
p. 77-81
|
artikel
|
| 9 |
Biomarkers in Duchenne Muscular Dystrophy
|
Lee-Gannon, Theo
|
|
|
|
2 |
p. 52-62
|
artikel
|
| 10 |
Biomarkers of Cardiac Stress and Injury in Athletes: What Do They Mean?
|
Donnellan, Eoin
|
|
2018
|
|
2 |
p. 116-122
|
artikel
|
| 11 |
Can Cognitive Behaviour Therapy Be Beneficial for Heart Failure Patients?
|
Lundgren, Johan
|
|
2014
|
|
2 |
p. 166-172
|
artikel
|
| 12 |
Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications
|
Drosatos, Konstantinos
|
|
2013
|
|
2 |
p. 109-121
|
artikel
|
| 13 |
Cardiac Ultrasound Imaging in Heart Failure: Recent Advances
|
Khan, Umar A.
|
|
2012
|
|
2 |
p. 154-161
|
artikel
|
| 14 |
Cardiovascular Responses to Heat Stress in Chronic Heart Failure
|
Cui, Jian
|
|
2014
|
|
2 |
p. 139-145
|
artikel
|
| 15 |
Challenges and Opportunities in Titrating Disease-Modifying Therapies in Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease
|
Enachi, Stefana
|
|
|
|
2 |
p. 101-112
|
artikel
|
| 16 |
Chemohypersensitivity and Autonomic Modulation of Venous Capacitance in the Pathophysiology of Acute Decompensated Heart Failure
|
Burchell, Amy E.
|
|
2013
|
|
2 |
p. 139-146
|
artikel
|
| 17 |
Chemotherapy-Induced Cardiotoxicity
|
Shaikh, Amir Y.
|
|
2012
|
|
2 |
p. 117-127
|
artikel
|
| 18 |
Chronic Right Ventricular Pacing in the Heart Failure Population
|
Gould, Justin
|
|
2018
|
|
2 |
p. 61-69
|
artikel
|
| 19 |
Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation
|
Gadela, Naga Vaishnavi
|
|
|
|
2 |
p. 52-63
|
artikel
|
| 20 |
Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives
|
Senthong, Vichai
|
|
2017
|
|
2 |
p. 106-116
|
artikel
|
| 21 |
Clinical Trial Report: Reevaluating Telemonitoring in Heart Failure
|
Florea, Viorel G.
|
|
2011
|
|
2 |
p. 84-86
|
artikel
|
| 22 |
Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET
|
Cleland, John G. F.
|
|
|
|
2 |
p. 82-88
|
artikel
|
| 23 |
Contrast Echocardiography in Heart Failure: Update 2023
|
Becher, Harald
|
|
|
|
2 |
p. 63-72
|
artikel
|
| 24 |
Current Practice in Patient Selecting for Long-Term Mechanical Circulatory Support
|
Halbreiner, M. S.
|
|
2014
|
|
2 |
p. 120-129
|
artikel
|
| 25 |
Current State of Ventricular Assist Devices
|
Caccamo, Marco
|
|
2011
|
|
2 |
p. 91-98
|
artikel
|
| 26 |
Current Status of Cell-Based Therapy for Heart Failure
|
Jakob, Philipp
|
|
2013
|
|
2 |
p. 165-176
|
artikel
|
| 27 |
Decision-Making Under Uncertainty in Advanced Heart Failure
|
Meyer, Theo E.
|
|
2014
|
|
2 |
p. 188-196
|
artikel
|
| 28 |
Decision Support Systems in HF based on Deep Learning Technologies
|
Penso, Marco
|
|
|
|
2 |
p. 38-51
|
artikel
|
| 29 |
Defining the Role for Percutaneous Mechanical Circulatory Support Devices for Medically Refractory Heart Failure
|
Kapur, Navin K.
|
|
2013
|
|
2 |
p. 177-184
|
artikel
|
| 30 |
Determinants of Survival Following Hospitalization for Acute Heart Failure
|
Jumean, Marwan F.
|
|
2014
|
|
2 |
p. 201-211
|
artikel
|
| 31 |
Digital Solutions to Optimize Guideline-Directed Medical Therapy Prescriptions in Heart Failure Patients: Current Applications and Future Directions
|
Man, Jelle P.
|
|
|
|
2 |
p. 147-161
|
artikel
|
| 32 |
Diuretic Resistance in Heart Failure
|
Gupta, Richa
|
|
2019
|
|
2 |
p. 57-66
|
artikel
|
| 33 |
Diuretic Strategies in Acute Decompensated Heart Failure
|
Hardin, E. Ashley
|
|
2017
|
|
2 |
p. 127-133
|
artikel
|
| 34 |
Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part II: Combination Therapy
|
J.J, Cuthbert
|
|
|
|
2 |
p. 115-130
|
artikel
|
| 35 |
Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions – Part I: Loop Diuretics
|
Cuthbert, Joseph James
|
|
|
|
2 |
p. 101-114
|
artikel
|
| 36 |
Diverse Molecular Forms of Plasma B-Type Natriuretic Peptide in Heart Failure
|
Nishikimi, Toshio
|
|
2011
|
|
2 |
p. 140-146
|
artikel
|
| 37 |
Does angiotensin receptor blockade improve outcomes in patients with heart failure and preserved ejection fraction? Results of the I-PRESERVE study
|
Krum, Henry
|
|
2009
|
|
2 |
p. 65-67
|
artikel
|
| 38 |
Efficacy of aldosterone receptor antagonism in heart failure: Potential mechanisms
|
Weber, Karl T.
|
|
|
|
2 |
p. 51-56
|
artikel
|
| 39 |
Electrical Muscle Stimulation for Chronic Heart Failure: An Alternative Tool for Exercise Training?
|
Banerjee, Prithwish
|
|
2010
|
|
2 |
p. 52-58
|
artikel
|
| 40 |
Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications
|
Kim, Youn-Hyun
|
|
2017
|
|
2 |
p. 117-126
|
artikel
|
| 41 |
Ethical Challenges of Deactivation of Cardiac Devices in Advanced Heart Failure
|
Chamsi-Pasha, Hassan
|
|
2014
|
|
2 |
p. 119-125
|
artikel
|
| 42 |
Evolutions in Combined Heart-Kidney Transplant
|
Jain, Rashmi
|
|
|
|
2 |
p. 139-146
|
artikel
|
| 43 |
Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease
|
Ramu, Bhavadharini
|
|
2016
|
|
2 |
p. 92-102
|
artikel
|
| 44 |
Exploring the Microbiome in Heart Failure
|
Kitai, Takeshi
|
|
2016
|
|
2 |
p. 103-109
|
artikel
|
| 45 |
Fabry Disease: Cardiac Implications and Molecular Mechanisms
|
Weissman, David
|
|
|
|
2 |
p. 81-100
|
artikel
|
| 46 |
Factors Related to Self-Care in Heart Failure Patients According to the Middle-Range Theory of Self-Care of Chronic Illness: a Literature Update
|
Jaarsma, Tiny
|
|
2017
|
|
2 |
p. 71-77
|
artikel
|
| 47 |
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis
|
Inciardi, Riccardo M.
|
|
2018
|
|
2 |
p. 106-115
|
artikel
|
| 48 |
Functional Adiponectin Resistance and Exercise Intolerance in Heart Failure
|
Van Berendoncks, An M.
|
|
2011
|
|
2 |
p. 113-122
|
artikel
|
| 49 |
Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
|
Chaikijurajai, Thanat
|
|
|
|
2 |
p. 23-32
|
artikel
|
| 50 |
Heart Failure and Obesity in Adults: Pathophysiology, Clinical Manifestations and Management
|
Alpert, Martin A.
|
|
2014
|
|
2 |
p. 156-165
|
artikel
|
| 51 |
Heart Failure: a Punch from the Gut
|
Mahenthiran, Ajay
|
|
|
|
2 |
p. 73-80
|
artikel
|
| 52 |
Heart Failure in Women
|
Taylor, Anne L.
|
|
2015
|
|
2 |
p. 187-195
|
artikel
|
| 53 |
High-Intensity Aerobic Interval Exercise in Chronic Heart Failure
|
Meyer, Philippe
|
|
2013
|
|
2 |
p. 130-138
|
artikel
|
| 54 |
How should COMET influence heart failure practice?
|
Adams, Kirkwood F.
|
|
|
|
2 |
p. 67-71
|
artikel
|
| 55 |
How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities
|
Javaheri, Ali
|
|
2016
|
|
2 |
p. 86-91
|
artikel
|
| 56 |
Iatrogenic Decompensated Heart Failure
|
Tran, Patrick
|
|
|
|
2 |
p. 21-27
|
artikel
|
| 57 |
Immune modulation: Role of the inflammatory cytokine cascade in the failing human heart
|
Satoh, Mamoru
|
|
2008
|
|
2 |
p. 69-74
|
artikel
|
| 58 |
Impact of Frailty on Heart Failure Prognosis: Is Sex Relevant?
|
Aguilar-Iglesias, Lara
|
|
|
|
2 |
p. 131-138
|
artikel
|
| 59 |
Inhibition of RAAS—When is it too much?
|
Navarro, Pablo
|
|
|
|
2 |
p. 57-64
|
artikel
|
| 60 |
Insights into natriuretic peptides in heart failure: An update
|
Korinek, Josef
|
|
2008
|
|
2 |
p. 97-104
|
artikel
|
| 61 |
Insulin resistance and heart failure
|
Heck, Patrick M.
|
|
2009
|
|
2 |
p. 89-94
|
artikel
|
| 62 |
Interactions between the sympathetic nervous system and the RAAS in heart failure
|
Goldsmith, Steven R.
|
|
|
|
2 |
p. 45-50
|
artikel
|
| 63 |
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
|
Askevold, Erik Tandberg
|
|
2014
|
|
2 |
p. 146-155
|
artikel
|
| 64 |
Interventions for Heart Failure Readmissions: Successes and Failures
|
Fleming, Lisa M.
|
|
2014
|
|
2 |
p. 178-187
|
artikel
|
| 65 |
Iron in Heart Failure: Friend or Foe?
|
Jelani, Qurat-ul-ain
|
|
2010
|
|
2 |
p. 49-51
|
artikel
|
| 66 |
Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options
|
Maisch, Bernhard
|
|
2014
|
|
2 |
p. 166-177
|
artikel
|
| 67 |
Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options
|
Maisch, Bernhard
|
|
|
|
2 |
p. 166-177
|
artikel
|
| 68 |
Markers of Immune Function in Heart Transplantation: Implications for Immunosuppression and Screening for Rejection
|
Zhuo, David X.
|
|
|
|
2 |
p. 33-40
|
artikel
|
| 69 |
Mineralocorticoid-receptor Antagonists in Heart Failure: A Tale of Serendipity and Success
|
Reyentovich, Alex
|
|
2011
|
|
2 |
p. 87-90
|
artikel
|
| 70 |
Mitochondria as Therapeutic Targets in Heart Failure
|
Schwemmlein, Julia
|
|
|
|
2 |
p. 27-37
|
artikel
|
| 71 |
Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical Trials
|
Singh, Prabhjot
|
|
2018
|
|
2 |
p. 44-52
|
artikel
|
| 72 |
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: How much is too much?
|
Pitt, Bertram
|
|
2009
|
|
2 |
p. 112-116
|
artikel
|
| 73 |
Neuregulin-1 Signaling in the Pathogenesis of Chemotherapy-Induced Heart Failure
|
Lenneman, Carrie Geisberg
|
|
2014
|
|
2 |
p. 134-138
|
artikel
|
| 74 |
Newer Applications of Nuclear Cardiology in Systolic Heart Failure: Detecting Coronary Artery Disease and Guiding Device Therapy
|
Friehling, Mati
|
|
2011
|
|
2 |
p. 106-112
|
artikel
|
| 75 |
Nitric oxide regulation of autonomic function in heart failure
|
Schultz, Harold D.
|
|
2009
|
|
2 |
p. 71-80
|
artikel
|
| 76 |
Nonadherence in the Advanced Heart Failure Population
|
Gandhi, Jonathan
|
|
2016
|
|
2 |
p. 77-85
|
artikel
|
| 77 |
Oral Sodium and Potassium Binders in Heart Failure
|
Morris, Alanna A.
|
|
2014
|
|
2 |
p. 107-111
|
artikel
|
| 78 |
Orexin: a Missing Link Between Sleep Disorders and Heart Failure?
|
Pan, Stephen
|
|
2017
|
|
2 |
p. 100-105
|
artikel
|
| 79 |
Pathophysiology and Potential Clinical Applications for Testing of Peripheral Chemosensitivity in Heart Failure
|
Niewinski, Piotr
|
|
2014
|
|
2 |
p. 126-133
|
artikel
|
| 80 |
Pathophysiology and Treatment Options for Cardiac Anorexia
|
Fudim, Marat
|
|
2011
|
|
2 |
p. 147-153
|
artikel
|
| 81 |
Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both?
|
Drosatos, Konstantinos
|
|
2014
|
|
2 |
p. 130-140
|
artikel
|
| 82 |
Percutaneous Ventricular Restoration with a Partitioning Device for Ischemic Heart Failure Treatment
|
Dhakal, Bishnu P.
|
|
2017
|
|
2 |
p. 87-99
|
artikel
|
| 83 |
Personalized Approach to Cancer Treatment–Related Cardiomyopathy
|
Slivnick, Jeremy
|
|
|
|
2 |
p. 43-55
|
artikel
|
| 84 |
Pharmacoepigenetics in Heart Failure
|
Mateo Leach, Irene
|
|
2010
|
|
2 |
p. 83-90
|
artikel
|
| 85 |
Pharmacologic management of patients with both heart failure and diabetes
|
MacDonald, Michael R.
|
|
2009
|
|
2 |
p. 126-132
|
artikel
|
| 86 |
Pharmacologic management of the cardiorenal syndrome in heart failure
|
Krum, Henry
|
|
2009
|
|
2 |
p. 105-111
|
artikel
|
| 87 |
Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy
|
Detopoulou, Paraskevi
|
|
2013
|
|
2 |
p. 122-129
|
artikel
|
| 88 |
Polypharmacy in Heart Failure Patients
|
Mastromarino, Vittoria
|
|
2014
|
|
2 |
p. 212-219
|
artikel
|
| 89 |
Potential Expanded Indications for Neprilysin Inhibitors
|
Riddell, Elizabeth
|
|
2017
|
|
2 |
p. 134-145
|
artikel
|
| 90 |
Preoperative Cardiac Risk Assessment for Noncardiac Surgery in Patients with Heart Failure
|
Upshaw, Jenica
|
|
2013
|
|
2 |
p. 147-156
|
artikel
|
| 91 |
Prognostic Value of Combining Echocardiography and Natriuretic Peptide Levels in Patients with Heart Failure
|
Yin, Wei-Hsian
|
|
2012
|
|
2 |
p. 148-153
|
artikel
|
| 92 |
Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection—Focus on Group II Pulmonary Hypertension
|
Ramu, Bhavadharini
|
|
2018
|
|
2 |
p. 81-93
|
artikel
|
| 93 |
Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction
|
Mwansa, Hunter
|
|
|
|
2 |
p. 41-51
|
artikel
|
| 94 |
Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure
|
Ramasamy, Ravichandran
|
|
2012
|
|
2 |
p. 107-116
|
artikel
|
| 95 |
Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
|
Lund, Lars H.
|
|
2017
|
|
2 |
p. 59-70
|
artikel
|
| 96 |
Relaxin: Review of Biology and Potential Role in Treating Heart Failure
|
Teichman, Sam L.
|
|
2010
|
|
2 |
p. 75-82
|
artikel
|
| 97 |
Renal Biomarkers of Kidney Injury in Cardiorenal Syndrome
|
Comnick, Mark
|
|
2011
|
|
2 |
p. 99-105
|
artikel
|
| 98 |
Respiratory muscle function and exercise intolerance in heart failure
|
Ribeiro, Jorge P.
|
|
2009
|
|
2 |
p. 95-101
|
artikel
|
| 99 |
Reverse Cardiac Remodeling and ARNI Therapy
|
Abboud, Andrew
|
|
|
|
2 |
p. 71-83
|
artikel
|
| 100 |
Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure
|
Raina, Amresh
|
|
2018
|
|
2 |
p. 94-105
|
artikel
|
| 101 |
Role of Heart Rate as a Marker and Mediator of Poor Outcome for Patients with Heart Failure
|
Kapoor, John R.
|
|
2012
|
|
2 |
p. 133-138
|
artikel
|
| 102 |
Role of Physical Training in Heart Failure with Preserved Ejection Fraction
|
Haykowsky, Mark
|
|
2012
|
|
2 |
p. 101-106
|
artikel
|
| 103 |
Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure
|
Parajuli, Daya Ram
|
|
2017
|
|
2 |
p. 78-86
|
artikel
|
| 104 |
Role of the Renal Lymphatic System in Heart Failure
|
Salah, Husam M.
|
|
|
|
2 |
p. 113-120
|
artikel
|
| 105 |
Role of Thyroid Hormones in Ventricular Remodeling
|
Rajagopalan, Viswanathan
|
|
2014
|
|
2 |
p. 141-149
|
artikel
|
| 106 |
Sex Differences in Acute Heart Failure Management: Is There a Gap in Treatment Quality?
|
Collado-Lledó, Elena
|
|
|
|
2 |
p. 121-128
|
artikel
|
| 107 |
Should aldosterone blockade be used beyond current indications in heart failure?
|
Smit, Marcelle D.
|
|
2009
|
|
2 |
p. 117-125
|
artikel
|
| 108 |
Sildenafil and phosphodiesterase-5 inhibitors for heart failure
|
Guazzi, Marco
|
|
2008
|
|
2 |
p. 110-114
|
artikel
|
| 109 |
Single-Cell RNA Sequencing of the Adult Mammalian Heart—State-of-the-Art and Future Perspectives
|
Gladka, Monika M.
|
|
|
|
2 |
p. 64-70
|
artikel
|
| 110 |
Skeletal Muscle Abnormalities in Chronic Heart Failure
|
Georgiadou, Panagiota
|
|
2012
|
|
2 |
p. 128-132
|
artikel
|
| 111 |
Sudden Death in Men Versus Women with Heart Failure
|
Martínez-Solano, Jorge
|
|
|
|
2 |
p. 129-137
|
artikel
|
| 112 |
Technology-Assisted Congestive Heart Failure Care
|
Iyngkaran, P.
|
|
2015
|
|
2 |
p. 173-186
|
artikel
|
| 113 |
Testosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications
|
Iellamo, Ferdinando
|
|
2010
|
|
2 |
p. 59-65
|
artikel
|
| 114 |
The Benefits of Revascularization in Chronic Heart Failure
|
Gurunathan, Sothinathan
|
|
2014
|
|
2 |
p. 112-119
|
artikel
|
| 115 |
The brain renin-angiotensin-aldosterone system: A major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction
|
Huang, Bing S.
|
|
2009
|
|
2 |
p. 81-88
|
artikel
|
| 116 |
The Evolving Role of Cardiorespiratory Fitness and Exercise in Prevention and Management of Heart Failure
|
Omar, Wally
|
|
2018
|
|
2 |
p. 75-80
|
artikel
|
| 117 |
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
|
Ibrahim, Nasrien E.
|
|
2018
|
|
2 |
p. 37-43
|
artikel
|
| 118 |
The Heart Failure with Preserved Ejection Fraction Conundrum—Redefining the Problem and Finding Common Ground?
|
Iyngkaran, P.
|
|
|
|
2 |
p. 34-42
|
artikel
|
| 119 |
The Importance of Assessing Nutritional Status in Elderly Patients with Heart Failure
|
Sargento, Luis
|
|
2014
|
|
2 |
p. 220-226
|
artikel
|
| 120 |
The Neurohormonal Network in the RAAS Can Bend Before Breaking
|
Wagman, Gabriel
|
|
2012
|
|
2 |
p. 81-91
|
artikel
|
| 121 |
The Psychosocial Treadmill: the Road to Improving High-risk Behavior in Advanced Therapy Candidates
|
Newman, Laura
|
|
2018
|
|
2 |
p. 70-74
|
artikel
|
| 122 |
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
|
Ueland, Thor
|
|
2012
|
|
2 |
p. 92-100
|
artikel
|
| 123 |
Traditional and Novel Imaging of Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction
|
Sciaccaluga, C.
|
|
|
|
2 |
p. 28-33
|
artikel
|
| 124 |
Transitions of Care in Heart Failure: The Case for Comparative Effectiveness Research
|
Piña, Ileana L.
|
|
2011
|
|
2 |
p. 81-83
|
artikel
|
| 125 |
Treating Hypertension in Patients with Left Ventricular Dysfunction: Hitting the Fairway and Avoiding the Rough
|
Joffe, Samuel W.
|
|
2013
|
|
2 |
p. 157-164
|
artikel
|
| 126 |
Tricuspid Valve Incompetence Following Implantation of Ventricular Leads
|
Baquero, Giselle A.
|
|
2014
|
|
2 |
p. 150-157
|
artikel
|
| 127 |
Uncoupling proteins in heart failure
|
Laskowski, Karl R.
|
|
2008
|
|
2 |
p. 75-79
|
artikel
|
| 128 |
Updates on Device-Based Therapies for Patients with Heart Failure
|
Al Danaf, Jad
|
|
2018
|
|
2 |
p. 53-60
|
artikel
|
| 129 |
Vasopressin and vasopressin antagonists in heart failure and hyponatremia
|
Farmakis, Dimitrios
|
|
2008
|
|
2 |
p. 91-96
|
artikel
|
| 130 |
Venous Congestion and Endothelial Cell Activation in Acute Decompensated Heart Failure
|
Ganda, Anjali
|
|
2010
|
|
2 |
p. 66-74
|
artikel
|
| 131 |
Vitamin D in Chronic Heart Failure
|
Witham, Miles D.
|
|
2011
|
|
2 |
p. 123-130
|
artikel
|
| 132 |
Web alert
|
|
|
2008
|
|
2 |
p. 57
|
artikel
|
| 133 |
What to Do About Primary-Prevention Implantable Cardiac Defibrillators in Patients with Improved Ejection Fraction
|
Naksuk, Niyada
|
|
2014
|
|
2 |
p. 197-200
|
artikel
|
Tijdschrift beschrijving